Most cited papers from BioInvent (Sweden)

BioInvent (Sweden)

What are the most cited papers from BioInvent (Sweden)?

The most cited paper from BioInvent (Sweden) is "Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies" (Frederick Arce Vargas et al., 2018), with 594 citations. Next come "Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries" (337) and "Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells" (287).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 21 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Frederick Arce Vargas et al. · Cancer Cell Open access255 authors	22 Mar 2018	594
2	Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries Eskil Söderlind, Leif Strandberg, Pernilla Jirholt et al. · Nature Biotechnology	Aug 2000	337
3	Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells Katrin J. Svensson, Paulina Kucharzewska, Helena C. Christianson et al. · Proceedings of the National Academy of Sciences Open access	25 Jul 2011	287
4	Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events Hamed Emami, Parmanand Singh, Megan H. MacNabb et al. · JACC. Cardiovascular imaging Open access	7 Jan 2015	264
5	Recombinant Antibodies to an Oxidized Low-Density Lipoprotein Epitope Induce Rapid Regression of Atherosclerosis in Apobec-1−/−/Low-Density Lipoprotein Receptor−/−Mice Alexandru Șchiopu, Björn Frendéus, Bo Jansson et al. · Journal of the American College of Cardiology Open access	Dec 2007	180
6	Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function Sarah L. Buchan et al. · Immunity Open access	Nov 2018	164
7	Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo Ali Roghanian et al. · Cancer Cell Open access	Apr 2015	135
8	Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies R. Carlsson, Christina Mårtensson, Suzanne Kalliomäki et al. · The Journal of Immunology	Feb 1992	105
9	Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus Venkat R Reddy, Geraldine Cambridge, David Alan Isenberg et al. · Arthritis & Rheumatology Open access	27 Apr 2015	102
10	Real Time Analysis of Antibody‐Antigen Reaction Kinetics Ann‐Christin Malmborg, Anne Michaelsson, Mats Ohlin et al. · Scandinavian Journal of Immunology	Jun 1992	100
11	Microarrays based on affinity‐tagged single‐chain Fv antibodies: Sensitive detection of analyte in complex proteomes Christer Wingren, Cornelia Steinhauer, Johan Ingvarsson et al. · PROTEOMICS	24 Feb 2005	94
12	Design of Recombinant Antibody Microarrays for Serum Protein Profiling: Targeting of Complement Proteins Johan Ingvarsson, Anette Larsson, Anders G. Sjöholm et al. · Journal of Proteome Research	16 Aug 2007	91
13	Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF Hanna Björkelund, Lars Gedda, Pavel Bárta et al. · PLoS ONE Open access	12 Sep 2011	85
14	Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework Pernilla Jirholt, Mats Ohlin, Carl A.K. Borrebaeck et al. · Gene	Jul 1998	84
15	Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity Andrew T. Vaughan, Chisako Iriyama, Stephen A. Beers et al. · Blood	14 Nov 2013	78
16	Automated Screening Procedure for High-Throughput Generation of Antibody Fragments Johan Hallborn, Roland N.K. Carlsson · BioTechniques Open access	Dec 2002	76
17	A Human ICAM-1 Antibody Isolated by a Function-First Approach Has Potent Macrophage-Dependent Antimyeloma Activity In Vivo Niina Veitonmäki, Markus Hansson, Fenghuang Zhan et al. · Cancer Cell Open access	Apr 2013	74
18	Wood morphology and properties from molecular perspectives Lennart Salmén · Annals of Forest Science Open access	3 Jul 2014	73
19	LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation Muchaala Yeboah et al. · JCI Insight Open access	Sep 2020	72
20	Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization Susanne M. Ohlsson, Petrus Linge, Birgitta Gullstrand et al. · Clinical Immunology	14 Mar 2014	70
21	Monoclonal Antibody TB-403: A First-in-Human, Phase I, Double-Blind, Dose Escalation Study Directed Against Placental Growth Factor in Healthy Male Subjects Titti Martinsson-Niskanen, Rikke Riisbro, Leonard Larsson et al. · Clinical Therapeutics	Sep 2011	59
22	Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB Ingrid Teige, Linda Mårtensson, Björn Frendéus · Frontiers in Immunology Open access	12 Mar 2019	56
23	Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412 Khiyam Hussain, Chantal E. Hargreaves, Ali Roghanian et al. · Blood Open access	14 Nov 2014	54
24	Human leukocyte immunoglobulin-like receptors in health and disease Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou et al. · Frontiers in Immunology Open access	13 Nov 2023	52
25	The hijackers guide to escaping complement: Lessons learned from pathogens David Ermert, Sanjay Ram, Maisem Laabei · Molecular Immunology Open access	20 Jul 2019	52
26	A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma Stina Wichert, Gunnar Juliusson, Åsa C. M. Johansson et al. · PLoS ONE Open access	3 Feb 2017	51
27	A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours Ulrik Lassen, Dorte Lisbet Nielsen, Morten Mau‐Sørensen et al. · British Journal of Cancer Open access	24 Jan 2012	50
28	A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma Markus Hansson, Peter Gimsing, Ashraf Z. Badros et al. · Clinical Cancer Research Open access	26 Feb 2015	49
29	Telomerase regulation and telomere dynamics in germinal centers Karl‐Fredrik Norrback, Magnus Hultdin, Katarina Dahlenborg et al. · European Journal Of Haematology	Nov 2001	49
30	Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques Shijie Li, Paul Kievit, Anna-Karin Robertson et al. · Molecular Metabolism Open access	11 Jun 2013	49
31	A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity Charlotte Welinder, Bo Baldetorp, Carl A.K. Borrebaeck et al. · Glycobiology	5 Apr 2011	47
32	Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors Alison L. Tutt et al. · The Journal of Immunology	29 Oct 2015	44
33	Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100 Åsa Ström, Gunilla Nordin Fredrikson, Alexandru Șchiopu et al. · Atherosclerosis	9 May 2006	43
34	Human CD4+ T cells expressing CD45RA acquire the lymphokine gene expression of CD45RO+ T-helper cells after activation in vitro. Karin Kristensson, Carl A.K. Borrebaeck, R. Carlsson · PubMed Open access	May 1992	40
35	Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes Anne Ljungars, Carolin Svensson, Anders Carlsson et al. · Frontiers in Pharmacology Open access	30 Jul 2019	37
36	Design of Recombinant Antibody Microarrays for Cell Surface Membrane Proteomics Linda Dexlin, Johan Ingvarsson, Björn Frendéus et al. · Journal of Proteome Research	30 Nov 2007	36
37	Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma B K Haller, Andreas Bråve, Elisabet Wallgard et al. · Oncogene	24 May 2010	35
38	Epitopes on CA 125 from Cervical Mucus and Ascites Fluid and Characterization of Six New Antibodies Kjell Nustad, Yuri S. Lebedin, Kenneth O. Lloyd et al. · Tumor Biology	2002	34
39	Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo Tetyana Levchenko, Niina Veitonmäki, Andrea Lundkvist et al. · The FASEB Journal	5 Nov 2007	34
40	Methodologies for model calibration to assist the design of a preparative ion-exchange step for antibody purification David Karlsson, Niklas Jakobsson, Karl-Johan Brink et al. · Journal of Chromatography A	10 Feb 2004	33
41	Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors Monika Semmrich, Jean‐Baptiste Marchand, Laetitia Fend et al. · Journal for ImmunoTherapy of Cancer Open access	2022	32
42	HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy Khiyam Hussain et al. · Journal of Experimental & Clinical Cancer Research Open access	7 Apr 2022	31
43	Single intravenous administration of TB‐402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose‐escalating, randomized, controlled trial Peter B. Verhamme, Marco J. D. Tangelder, Raymond Verhaeghe et al. · Journal of Thrombosis and Haemostasis Open access	Feb 2011	31
44	Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose β1-3 N-acetyl-galactosamine) Lu‐Gang Yu, Bo Jansson, David Garth Fernig et al. · International Journal of Cancer	4 Nov 1997	30
45	A new look at drugs targeting malignant melanoma—An application for mass spectrometry imaging Yutaka Sugihara, Ákos Végvári, Charlotte Welinder et al. · PROTEOMICS	18 Jul 2014	29
46	Phenotypical and Functional Differentiation of CD4+ CD45RA+ Human T Cells Following Polyclonal Activation Karin Kristensson, Mikael Dohlsten, Hans Fischer et al. · Scandinavian Journal of Immunology	Sep 1990	28
47	Domain binding and isotype dictate the activity of anti-human OX40 antibodies Jordana Griffiths et al. · Journal for ImmunoTherapy of Cancer Open access	Dec 2020	27
48	Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions Isabel Gonçalves, Mihaela Nitulescu, Mikko P.S. Ares et al. · Atherosclerosis	Dec 2008	27
49	FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms Alexander P. Simpson, Ali Roghanian, Robert J. Oldham et al. · Cell Reports Open access	Jul 2022	26
50	Rapid induction of apoptosis in B‐cell lymphoma by functionally isolated human antibodies Johan Fransson, Ulla‐Carin Tornberg, Carl A.K. Borrebaeck et al. · International Journal of Cancer Open access	13 Feb 2006	25

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.